Cancer screening among migrants in an Australian cohort; cross-sectional analyses from the 45 and Up Study

Weber, Marianne F.; Banks, Emily; Smith, David P.; O'Connell, Dianne; Sitas, Freddy
January 2009
BMC Public Health;2009, Vol. 9 Issue 1, p1
Academic Journal
Background: Limited evidence suggests that people from non-English speaking backgrounds in Australia have lower than average rates of participation in cancer screening programs. The objective of this study was to examine the distribution of bowel, breast and prostate cancer test use by place of birth and years since migration in a large population-based cohort study in Australia. Methods: In 2006, screening status, country of birth and other demographic and health related factors were ascertained by self-completed questionnaire among 31,401 (16,126 women and 15,275 men) participants aged 50 or over from the 45 and Up Study in New South Wales. Results: 35% of women and 39% of men reported having a bowel cancer test and 57% of men reported having a prostate specific antigen (PSA) test, in the previous 5 years. 72% of women reported having screening mammography in the previous 2 years. Compared to Australian-born women, women from East Asia, Southeast Asia, Continental Western Europe, and North Africa/ Middle East had significantly lower rates of bowel testing, with odds ratios (OR; 95%CI) ranging from 0.5 (0.4-0.7) to 0.7 (0.6-0.9); migrants from East Asia (0.5, 0.3-0.7) and North Africa/Middle East (0.5, 0.3-0.9) had significantly lower rates of mammography. Compared to Australian-born men, bowel cancer testing was significantly lower among men from all regions of Asia (OR, 95%CI ranging from 0.4, 0.3-0.6 to 0.6, 0.5-0.9) and Continental Europe (OR, 95%CI ranging from 0.4, 0.3-0.7 to 0.7, 0.6-0.9). Only men from East Asia had significantly lower PSA testing rates than Australian-born men (0.4, 0.3-0.6). As the number of years lived in Australia increased, cancer test use among migrants approached Australian-born rates. Conclusion: Certain migrant groups within the population may require targeted intervention to improve their uptake of cancer screening, particularly screening for bowel cancer.


Related Articles

  • Study finds nonEnglish speaking head and neck cancer patients have significantly worse outcomes.  // Biomedical Market Newsletter;10/10/2011, Vol. 21, p233 

    The article reports on the study from the Boston Medical Center and Boston University School of Medicine which found that being a non-English speaker in neck and head cancer patients was a key predictor of treatment outcome.

  • KATIE'S CURE. Gupta, Sanjay; Gajilan, A. Chris // Time International (South Pacific Edition);4/10/2006, Issue 14, p67 

    The article focuses on the campaign initiated by television show host Katie Couric to raise awareness about the importance of regular medical screenings for cancer. A study of more than 160,000 colon-cancer patients published in the Archives of Internal Medicine found that the cancers of...

  • NO PSA Testing for Older Men.  // Clinician Reviews;Sep2008, Vol. 18 Issue 9, p10 

    The article discusses research being done on prostate-specific antigen (PSA) screening for prostate cancer in older men in the U.S. It references a study by K. Lin, R. Lipsitz, T. Miller and S. Janakiraman, published in the 2008 issue of the "Annals of Internal Medicine." Lin and colleagues...

  • No advantage in screening for endometrial cancer. Gottlieb, Scott // BMJ: British Medical Journal (International Edition);10/28/2000, Vol. 321 Issue 7268, p1039 

    Discusses the ineffectiveness of routine endometrial screening for breast cancer patients being treated with tamoxifen. Details of two studies to evaluate the diagnostic value of such screening methods; Risk factors associated with endometrial biopsy and transvaginal ultrasonography; Statistics...

  • Waiting times from abnormal breast screen to diagnosis in 7 Canadian provinces. Olivotto, Ivo A.; Bancej, Christina; Goel, Vivek; Snider, Judy; McAuley, Ronald G.; Irvine, Brenda; Kan, Lisa; Mirsky, Doug; Sabine, Margaret J.; McGilly, Renee; Caines, Judy S. // CMAJ: Canadian Medical Association Journal;8/7/2001, Vol. 165 Issue 3, p277 

    Interpretation: Women undergoing assessment of an abnormal breast cancer screening result waited many weeks for a diagnosis, especially when a biopsy was performed. To ensure that targets for timeliness, adopted nationally in 1999, are realized, improved models of care or dissemination of...

  • Rethinking breast cancer--again. Baines, Cornealia J. // BMJ: British Medical Journal (International Edition);10/29/2005, Vol. 331 Issue 7523, p1031 

    The article focuses on a renewed interest in breast cancer screening. There is a reference to Maureen Roberts, clinical director of the Edinburgh breast screening project, who had breast cancer. The discovery of breast cancer in the deputy director of the Canadian national breast screening study...

  • Screening cuts colonoscopies.  // Pulse;3/1/2007, Vol. 67 Issue 8, p16 

    The article reports on a study conducted to 1,124 colorectal cancer patients aged 56-69 to investigate the efficacy of faecal immunochemical tests as a disease detection strategy in Scotland. Such trial implies that detection rates was an efficient and effective disease detection strategy, since...

  • Breast-cancer screening saves lives even though it also picks up cases in some women that would never have caused them a problem, according to a review published in The Lancet medical journal.  // MondayMorning;11/ 5/2012, Vol. 20 Issue 42, p1 

    The article focuses on the importance of routine medical screening in women against breast cancer. It informs that breast cancer screening offers several benefits to women as it can identify other problem that are not diagnosed previously. It further states that screening has prevented about...

  • Nutrition screening tools for patients with cancer.  // Nursing Standard;11/21/2007, Vol. 22 Issue 11, p14 

    The article reports on the research by nurses at the University of Alberta in Canada which evaluates the three recommended screening tools for use by clinicians in oncology settings in the country. These include the patient generated subjective global assessment, mini nutritional assessment and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics